Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Viruses|April 3, 2021
The Appropriateness of Invasive Ventilation in COVID-19 Positive Cancer Patients: Proposal of a New Prognostic ScoreMichele Ghidini, Alice Indini, Erika Rijavec, et al.
Annals of Gastroenterology|November 21, 2022
Immune checkpoint inhibitor therapy for hepatocellular carcinomaDaryl Ramai, Alexandra Shapiro, Antonio Facciorusso, et al.
BMC Cancer|October 28, 2021
Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profilingElham Sajjadi, Konstantinos Venetis, Roberto Piciotti, et al.
Journal of Visualized Experiments : Jove|February 25, 2020
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and DiagnosisMarco Invernizzi, Letterio Runza, Alessandro De Sire, et al.
Anticancer Research|December 16, 2014
Sunitinib-induced complete response in metastatic renal cancer expressing neuroendocrine markers: a new predictive factor?Donatella Gambini, Elisa Locatelli, Umberto Gianelli, et al.
International Journal of Molecular Sciences|April 3, 2021
Impact of BMI on Survival Outcomes of Immunotherapy in Solid Tumors: A Systematic ReviewAlice Indini, Erika Rijavec, Michele Ghidini, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 31, 2017
Columnar Cell Lesion and Apocrine Hyperplasia of the Breast: Is There a Common Origin? The Role of Prolactin-induced ProteinAmedeo Sciarra, Gianluca Lopez, Chiara Corti, et al.
Journal of Visualized Experiments : Jove|December 30, 2017
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast CancersGiulia Ercoli, Gianluca Lopez, Camilla Ciapponi, et al.
Expert Opinion on Pharmacotherapy|March 13, 2020
Pharmacotherapeutic advances with anaplastic lymphoma kinase inhibitors for the treatment of non-small cell lung cancerAlice Indini, Erika Rijavec, Michele Ghidini, et al.
Cancers|January 8, 2025
A Prospective Monocentric Study of Invasive Breast Carcinoma Diagnosed at 80 Years and Older: Survival Outcomes and Peculiar ChallengesDonatella Gambini, Valentina Veronesi, Luca Despini, et al.
Pageof 3